MSF Welcomes New Fixed-Dose Combination Against Malaria
May 15th 2008Drug InformationTropical
Doctors Without Borders/Medecins Sans Frontieres (MSF) welcomes the launch in Brazil of a new drug against P. Falciparum, the most dangerous type of malaria. Developed by DNDi (Drugs for Neglected Diseases Initiative) in partnership with Farmanguinhos/Fiocruz, ASMQ is the first drug against malaria that combines artesunate (AS) and mefloquine (MQ) in one fixed dose.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
